Ability of two commercially available assays (Abbott RealTime HIV-1 and Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2.0) to quantify low HIV-1 RNA levels (

Research output: Contribution to journalArticle

Abstract

Concordance between molecular assays may be suboptimal at low HIV-1 viremia levels (

Original languageEnglish
Pages (from-to)2019-2026
Number of pages8
JournalJournal of Clinical Microbiology
Volume52
Issue number6
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Ability of two commercially available assays (Abbott RealTime HIV-1 and Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2.0) to quantify low HIV-1 RNA levels ('. Together they form a unique fingerprint.

  • Cite this